View in EDS HTML Full Text PDF Full Text

Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.

Saved in:
Bibliographic Details
Title: Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
Authors: Cirulli GO; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Davis M; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Stephens A; Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA., Chiarelli G; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Finati M; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy., Chase M; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Tinsley S; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Arora S; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Sood A; Department of Urology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, US., Lughezzani G; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Buffi N; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Carrieri G; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy., Salonia A; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Briganti A; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Montorsi F; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Rogers C; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA., Abdollah F; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.
Source: Cancer [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35563. Date of Electronic Publication: 2024 Oct 08.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39377255
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cirulli+GO%22">Cirulli GO</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Davis+M%22">Davis M</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+A%22">Stephens A</searchLink>; Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Chiarelli+G%22">Chiarelli G</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Finati+M%22">Finati M</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.<br /><searchLink fieldCode="AU" term="%22Chase+M%22">Chase M</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Tinsley+S%22">Tinsley S</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Arora+S%22">Arora S</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Sood+A%22">Sood A</searchLink>; Department of Urology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio, US.<br /><searchLink fieldCode="AU" term="%22Lughezzani+G%22">Lughezzani G</searchLink>; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Buffi+N%22">Buffi N</searchLink>; Department of Urology, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Carrieri+G%22">Carrieri G</searchLink>; Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.<br /><searchLink fieldCode="AU" term="%22Salonia+A%22">Salonia A</searchLink>; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Briganti+A%22">Briganti A</searchLink>; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Montorsi+F%22">Montorsi F</searchLink>; Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Rogers+C%22">Rogers C</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Abdollah+F%22">Abdollah F</searchLink>; VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35563. <i>Date of Electronic Publication: </i>2024 Oct 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39377255
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.35563
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e35563
    Titles:
      – TitleFull: Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cirulli GO
      – PersonEntity:
          Name:
            NameFull: Davis M
      – PersonEntity:
          Name:
            NameFull: Stephens A
      – PersonEntity:
          Name:
            NameFull: Chiarelli G
      – PersonEntity:
          Name:
            NameFull: Finati M
      – PersonEntity:
          Name:
            NameFull: Chase M
      – PersonEntity:
          Name:
            NameFull: Tinsley S
      – PersonEntity:
          Name:
            NameFull: Arora S
      – PersonEntity:
          Name:
            NameFull: Sood A
      – PersonEntity:
          Name:
            NameFull: Lughezzani G
      – PersonEntity:
          Name:
            NameFull: Buffi N
      – PersonEntity:
          Name:
            NameFull: Carrieri G
      – PersonEntity:
          Name:
            NameFull: Salonia A
      – PersonEntity:
          Name:
            NameFull: Briganti A
      – PersonEntity:
          Name:
            NameFull: Montorsi F
      – PersonEntity:
          Name:
            NameFull: Rogers C
      – PersonEntity:
          Name:
            NameFull: Abdollah F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 131
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1